Connor, Clark & Lunn Investment Management (CC&L)’s Terns Pharmaceuticals TERN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-74,858
| Closed | -$415K | – | 1597 |
|
|
2024
Q4 | $415K | Buy |
74,858
+21,845
| +41% | +$121K | ﹤0.01% | 1190 |
|
|
2024
Q3 | $442K | Buy |
+53,013
| New | +$442K | ﹤0.01% | 1126 |
|
|
2023
Q4 | – | Sell |
-67,957
| Closed | -$342K | – | 1555 |
|
|
2023
Q3 | $342K | Sell |
67,957
-4,230
| -6% | -$21.3K | ﹤0.01% | 1116 |
|
|
2023
Q2 | $632K | Buy |
72,187
+60,224
| +503% | +$527K | ﹤0.01% | 927 |
|
|
2023
Q1 | $142K | Buy |
+11,963
| New | +$142K | ﹤0.01% | 1129 |
|